发明名称 TETRALINES
摘要 Compounds of formula (I) wherein R1 and R2, independently, are hydrogen (C1-4)alkyl, (C1-4)alkoxy, (C1-4)alkylthio, halogen, trifluoromethyl, trifluoromethoxy, cyano, (C2-5)alkanoyl, (C1-4)alkylsulfonyl or sulfamoyl; R3 is hydrogen, hydroxy, (C1-4)alkyl, (C1-4)alkoxy, halogen, cyano, (C2-5)alkanoyl, carbamoyl, (C1-4)alkylsulfonyloxy or trifluoromethylsulfonyloxy; and R4 and R5, independently, are hydrogen, (C1-4)alkyl, hydroxy(C2-4)alkyl or phenyl(C1-4)alkyl, or form together with the nitrogen atom to which they are attached a pyrrolidinyl, piperidino or piperazinyl group, in free base or acid addition salt form. Compounds according to formula (1) are useful in the treatment of epilepsy, stroke and brain or spinal trauma.
申请公布号 CA2217855(C) 申请公布日期 2008.12.09
申请号 CA19962217855 申请日期 1996.05.03
申请人 NOVARTIS AG 发明人 SWOBODA, ROBERT
分类号 C07C217/74;C07D295/08;A61K31/135;A61K31/16;A61K31/165;A61K31/166;A61K31/255;A61K31/275;A61K31/40;A61K31/445;A61K31/495;A61P9/10;A61P25/00;A61P25/08;C07C211/42;C07C213/00;C07C215/64;C07C217/54;C07C225/20;C07C237/48;C07C255/58;C07C255/59;C07C309/65;C07C311/39;C07C317/32;C07C323/31;C07D295/02;C07D295/033;C07D295/073;C07D295/096 主分类号 C07C217/74
代理机构 代理人
主权项
地址